Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
Duc Minh PhamJung Kwon KimSangchul LeeSung Kyu HongSeok-Soo ByunSang Eun LeePublished in: Investigative and clinical urology (2020)
A substantial proportion of patients with GS 3+4 prostate cancer were upgraded after RP. However, according to our model combining clinical and imaging predictors, patients with a low risk of GS upgrading may be eligible candidates for AS.